Salt Lake City, August 1, 2018: Mountain Pacific Venture Partners, a Salt Lake City-based venture capital firm, has closed the first institutional investment into its debut fund, which invests in and supports innovative life science and biotech companies. The investment into Mountain Pacific Venture Fund was made by TY BIO Investment, Inc., a wholly-owned subsidiary […]
FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of Legislation to Permanently Repeal the Medical Device Tax Salt Lake City – BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of […]
Please join us and Global Genes on Saturday, June 30th for RARE on the Road Rare Disease Leadership Tour in Salt Lake City, Utah. This conference will educate rare disease patients, caregivers and other advocates through collaboration in an interactive and engaging environment.
Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urology markets.
Joins us for a timely update from Brian Carey, Partner, Foley Hoag, on reimbursement trends for precision medicine and Kim Linthicum, Vice President of Government Affairs, Myriad, on proposed legislation that would create a new regulatory pathway for diagnostics.
The MedTech Conference will take place on September 24th – 26th 2018 at the Pennsylvania Convention Center in Philadelphia.
The Center for Technology & Venture Commercialization at the University of Utah announced a new funding program for early stage technology development and commercialization.
We officially commenced clinical evaluation of IDCT for degenerative disc disease last month, and just yesterday, announced the first patient has been treated in our U.S. Phase I/II trial.
SALT LAKE CITY–(BUSINESS WIRE)–Utah life sciences companies, and BioUtah members, ProLung, Inc., and Rosivo Inc., were among ten innovative companies announced as winners in the 16th annual Utah Innovation Awards, presented by Stoel Rives, LLP, and the Utah Technology Council. Winners were honored during a special awards dinner, April 26, at the Hilton Salt Lake […]
Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions.
On April 22, the Daily Herald published an article highlighting Tolero Pharmaceuticals’ research in “personalized medicine.” This concept is based on the idea that drugs can be more effective once doctors know whether or not they will be right for specific patients. “It’s the right drug for the right patient for the right disease,” said Kelly Slone, president […]
Jim Greenwood, CEO of BIO, acknowledges Senator Hatch for his groundbreaking work in biotechnology policy following his honors at BIO’s 25 Years of Innovation this month.
